Livzon Pharmaceutical (000513.CH) - A Good Company that You Can't Afford Missing
This article analyzed Livzon's R&D highlights, main products and pipelines, financial position, and made forecast and rating for the Company.
446 Views
Shanghai/Shenzhen Connect Flows: New High of Holdings by Offshore Money
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
290 Views
Shanghai/Shenzhen Connect Ideas: Pre-Mid Autumn Hard Liquor Outflows (2019-09-13)
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
320 Views
Shanghai/Shenzhen Connect Ideas: YTD High Inflows of $4b (2019-09-06)
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
367 Views
The China A-Share Revolution
Copley Fund Research analyse the holdings of long-only Global Emerging Market equity funds. All of the Funds in this analysis are actively managed...
961 Views